# Measuring Acute Drug Demand in Humans

> **NCT05829655** · EARLY_PHASE1 · SUSPENDED · sponsor: **University of Maryland, Baltimore** · enrollment: 75 (estimated)

## Conditions studied

- Opioid Use Disorder
- Opioid Dependence

## Interventions

- **DRUG:** Drug A (Blinded Drug)
- **DRUG:** Drug B (Blinded Drug)
- **DRUG:** Drug C (Blinded Drug)
- **DRUG:** Drug D (Blinded Drug)
- **DRUG:** Suvorexant (20mg/day)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05829655
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-08-08
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 75 (ESTIMATED)
- **Why stopped:** The trial is currently paused during a move to a new institution and acquisition of the new IRB approval at University of Maryland, Baltimore
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05829655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05829655, "Measuring Acute Drug Demand in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05829655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*